Zuranolone to face challenges in Japan’s MDD market despite demonstrating rapid onset of action, says GlobalData - PharmaLive

Submitted by Anonymous (not verified) on Tue, 10/22/2024 - 03:50

Zuranolone to face challenges in Japan’s MDD market despite demonstrating rapid onset of action, says GlobalData  PharmaLive